51. Silver Nanoparticles Synthesized Using Wild Mushroom Show Potential Antimicrobial Activities against Food Borne Pathogens.
- Author
-
Mohanta YK, Nayak D, Biswas K, Singdevsachan SK, Abd Allah EF, Hashem A, Alqarawi AA, Yadav D, and Mohanta TK
- Subjects
- Anti-Bacterial Agents pharmacology, Antineoplastic Agents, Phytogenic pharmacology, Antioxidants pharmacology, Bacillus subtilis drug effects, Cell Line, Enterococcus faecalis drug effects, Escherichia coli drug effects, Food Microbiology, Green Chemistry Technology, Humans, Listeria drug effects, MCF-7 Cells, Microbial Sensitivity Tests, Micrococcus luteus drug effects, Particle Size, Silver pharmacology, Agaricales chemistry, Anti-Bacterial Agents chemistry, Antineoplastic Agents, Phytogenic chemistry, Antioxidants chemistry, Metal Nanoparticles chemistry, Silver chemistry
- Abstract
The present study demonstrates an economical and eco-friendly method for the synthesis of silver nanoparticles (AgNPs) using the wild mushroom Ganoderma sessiliforme . The synthesis of AgNPs was confirmed and the products characterized by UV-visible spectroscopy, dynamic light scattering spectroscopy and X-ray diffraction analysis. Furthermore, Fourier transform infrared spectroscopy (ATR-FTIR) analysis was performed to identify the viable biomolecules involved in the capping and active stabilization of AgNPs. Moreover, the average sizes and morphologies of AgNPs were analyzed by field emission scanning electron microscopy (FE-SEM). The potential impacts of AgNPs on food safety and control were evaluated by the antimicrobial activity of the synthesized AgNPs against common food-borne bacteria, namely, Escherichia coli , Bacillus subtilis , Streptococcus faecalis , Listeria innocua and Micrococcus luteus . The results of this study revealed that the synthesized AgNPs can be used to control the growth of food-borne pathogens and have potential application in the food packaging industry. Moreover, the AgNPs were evaluated for antioxidant activity (aDPPH), for biocompatibility (L-929, normal fibroblast cells), and for cytotoxic effects on human breast adenosarcoma cells (MCF-7 & MDA-MB231) to highlight their potential for use in a variety of bio-applications., Competing Interests: The authors declare no conflict of interest.
- Published
- 2018
- Full Text
- View/download PDF